LONG-TERM TREATMENT OF SEVERE HYPERTENSION WITH MINOXIDIL
- 1 January 1977
- journal article
- research article
- Vol. 117 (10) , 1178-+
Abstract
Minoxidil, a new potent hypotensive agent, was used as the primary antihypertensive agent in 11 patients, 10 men and 1 woman aged 35-54 yr with severe hypertension that was refractory to treatment with maximal (or maximally tolerated) doses of conventional antihypertensive agents. Six patients had severely impaired renal function and 3 of them were undergoing long-term hemodialysis. The patients were given 2.5-40 mg/day of minoxidil for periods of 2 to 29 mo. All except 1 who was almost anuric received propranolol and diuretics. Blood pressure was controlled satisfactorily in all patients. In 2 patients the hypertension became partially resistant after 1 yr of treatment. The main side effects were Na retention, tachycardia and hirsutism. Renal function remained stable or improved and hemodialysis was discontinued in 2 patients. Minoxidil is a remarkably potent hypotensive with relatively few side effects and seems particularly advantageous in patients with chronic renal failure.This publication has 12 references indexed in Scilit:
- Minoxidil therapy in children with severe hypertensionThe Journal of Pediatrics, 1977
- Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.Circulation, 1975
- Minoxidil in severe hypertension: Value when conventional drugs have failedAmerican Heart Journal, 1975
- Severe hypertension. Treatment with minoxidil.1975
- Vasodilator drugs in the treatment of hypertension.1974
- Vasodilation for Vasospastic HypertensionNew England Journal of Medicine, 1973
- Minoxidil — An Alternative to Nephrectomy for Refractory HypertensionNew England Journal of Medicine, 1973
- Minoxidil in severe hypertension with renal failure: Effect of its addition to conventional antihypertensive drugsThe American Journal of Cardiology, 1973
- Pharmacologic properties of minoxidil: a new hypotensive agent.1973
- Re-Examination of the Hemodynamics of HypertensionThe Lancet Healthy Longevity, 1969